Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · IEX Real-Time Price · USD
116.79
+1.05 (0.91%)
At close: Jul 19, 2024, 4:00 PM
117.29
+0.50 (0.43%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Lantheus Holdings Employees
Lantheus Holdings had 834 employees as of December 31, 2023. The number of employees increased by 136 or 19.48% compared to the previous year.
Employees
834
Change (1Y)
136
Growth (1Y)
19.48%
Revenue / Employee
$1,637,434
Profits / Employee
$552,199
Market Cap
8.10B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 834 | 136 | 19.48% |
Dec 31, 2022 | 698 | 86 | 14.05% |
Dec 31, 2021 | 612 | 17 | 2.86% |
Dec 31, 2020 | 595 | 87 | 17.13% |
Dec 31, 2019 | 508 | 20 | 4.10% |
Dec 31, 2018 | 488 | 5 | 1.04% |
Dec 31, 2017 | 483 | 18 | 3.87% |
Dec 31, 2016 | 465 | -9 | -1.90% |
Dec 31, 2015 | 474 | -50 | -9.54% |
Dec 31, 2014 | 524 | 5 | 0.96% |
Dec 31, 2013 | 519 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
The Ensign Group | 35,300 |
Chemed | 15,087 |
Bio-Rad Laboratories | 8,030 |
Bio-Rad Laboratories | 8,030 |
Roivant Sciences | 908 |
Ascendis Pharma | 879 |
Intra-Cellular Therapies | 610 |
LNTH News
- 4 days ago - Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time - GlobeNewsWire
- 6 days ago - Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer's Disease - GlobeNewsWire
- 11 days ago - Lantheus Welcomes CMS' Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access - GlobeNewsWire
- 13 days ago - Lantheus Appoints Jamie Spaeth as Chief People Officer - GlobeNewsWire
- 25 days ago - Lantheus Acquires Global Rights to Life Molecular Imaging's Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers - GlobeNewsWire
- 4 weeks ago - Radiopharm Receives Strategic Investment for up to A$18 million - GlobeNewsWire
- 6 weeks ago - Lantheus' AI-Enabled aPROMISE Now Available on Siemens Healthineers' syngo.via platform - GlobeNewsWire
- 7 weeks ago - Lantheus to Present at the William Blair 44th Annual Growth Stock Conference - GlobeNewsWire